Cargando…

Partial remission of advanced untreated Sézary syndrome after COVID-19

Detalles Bibliográficos
Autores principales:	Snowden, Caroline, Ng, Spencer, Choi, Jaehyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734171/ https://www.ncbi.nlm.nih.gov/pubmed/35013712 http://dx.doi.org/10.1016/j.jdcr.2021.12.005

Ejemplares similares

Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome
por: Hosoi, Hiroki, et al.
Publicado: (2018)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

Plantar keratoderma of Sézary syndrome
por: Fragkos, Konstantinos C.
Publicado: (2017)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
por: Moerman-Herzog, Andrea, et al.
Publicado: (2020)

COVID-19 infection in patients with Sézary syndrome: report of three cases
por: Granara, Martina, et al.
Publicado: (2021)

Pembrolizumab-associated tumor development in a patient with Sézary syndrome
por: Malachowski, Stephen J., et al.
Publicado: (2019)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Integrated Genomic Analysis of Sézary Syndrome
por: Mao, Xin, et al.
Publicado: (2011)

A mouse model for the Sézary syndrome
por: Doebbeling, Udo
Publicado: (2010)

Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
por: Oka, Tomonori, et al.
Publicado: (2019)

Sezary syndrome, thyroid carcinoma, and renal carcinoma in a patient with Poland syndrome
por: Kuzyk, Alexandra, et al.
Publicado: (2021)

Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient
por: Lolli, Ginevra, et al.
Publicado: (2020)

Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
por: Kanda-Kato, Madoka, et al.
Publicado: (2020)

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
por: Brumfiel, Caitlin M., et al.
Publicado: (2020)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
por: Egger, Andjela, et al.
Publicado: (2020)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
por: Miyashiro, Denis, et al.
Publicado: (2022)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides
por: Campbell, Belinda A., et al.
Publicado: (2019)

The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist’s Point of View
por: Giordano, Antonio, et al.
Publicado: (2022)

Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
por: Karadağ, Yeşim S., et al.
Publicado: (2013)

EPHA4 is overexpressed but not functionally active in Sézary syndrome
por: Hameetman, Liesbeth, et al.
Publicado: (2015)

New Insights Into the Complex Mutational Landscape of Sézary Syndrome
por: Mirza, Abu-Sayeef, et al.
Publicado: (2020)

The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
por: Liu, Zhaorui, et al.
Publicado: (2021)

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
por: Robertson, Jake C, et al.
Publicado: (2021)

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
por: Dobos, Gabor, et al.
Publicado: (2023)

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)
por: Levy, Ilana, et al.
Publicado: (2023)

Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome
por: Zhang, Yumeng, et al.
Publicado: (2020)

Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome
por: Manfrere, Kelly C. G., et al.
Publicado: (2016)

Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma
por: Muszbek, Noemi, et al.
Publicado: (2023)

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
por: Quadri, Iman, et al.
Publicado: (2023)

Sézary Syndrome with CD4/CD8 Double-Negative Neoplastic T Cells in Peripheral Blood
por: Kageyama, Yuki, et al.
Publicado: (2021)

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
por: Vural, Seçil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_63qfrc9lj5a7445537jo64nu15